I agree - it was never mentioned - perhaps discussions at FDA lead to a reduced potency level for safety concerns?
either way an approval is an approval and the difference of 2.55% is not a deal breaker for anyone. in japan selling at 5% and 40% growth YOY or was it quarter.?
Ann: Trading Halt, page-76
-
- There are more pages in this discussion • 264 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.005(1.33%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 38.0¢ | 36.0¢ | $2.725M | 7.415M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 70075 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 422900 | 17 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |